nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome
|
Teriaca, M.A. |
|
|
155 |
C |
p. 232-236 |
artikel |
2 |
A qualitative classification signature for post-surgery 5-fluorouracil-based adjuvant chemoradiotherapy in gastric cancer
|
Li, Meifeng |
|
|
155 |
C |
p. 65-72 |
artikel |
3 |
A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy
|
Kothari, Gargi |
|
|
155 |
C |
p. 188-203 |
artikel |
4 |
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial
|
Hirose, Katsumi |
|
|
155 |
C |
p. 182-187 |
artikel |
5 |
Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer
|
Wortman, B.G. |
|
|
155 |
C |
p. 160-166 |
artikel |
6 |
Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era
|
Luo, Wei-Jie |
|
|
155 |
C |
p. 56-64 |
artikel |
7 |
Comment on: Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, by Onal C et al.
|
Goyal, Shikha |
|
|
155 |
C |
p. e13-e14 |
artikel |
8 |
Contents
|
|
|
|
155 |
C |
p. iii-vi |
artikel |
9 |
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2
|
Jereczek-Fossa, Barbara Alicja |
|
|
155 |
C |
p. 120-122 |
artikel |
10 |
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy
|
Rosen, Benjamin S. |
|
|
155 |
C |
p. 174-181 |
artikel |
11 |
Current delivery limitations of proton PBS for FLASH
|
Zou, Wei |
|
|
155 |
C |
p. 212-218 |
artikel |
12 |
Definitive radiotherapy for prostate cancer in Norway 2006–2015: Temporal trends, performance and survival
|
Fosså, Sophie D. |
|
|
155 |
C |
p. 33-41 |
artikel |
13 |
Development of staffing, workload and infrastructure in member departments of the European Organisation for Research and Treatment of Cancer (EORTC) radiation oncology group
|
Willmann, Jonas |
|
|
155 |
C |
p. 226-231 |
artikel |
14 |
Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma
|
Sertorio, Mathieu |
|
|
155 |
C |
p. 293-303 |
artikel |
15 |
Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: A phase I trial (GASTO-1021)
|
Chen, Nai-Bin |
|
|
155 |
C |
p. 105-112 |
artikel |
16 |
Dosimetric parameters associated with radiation-induced esophagitis in breast cancer patients undergoing regional nodal irradiation
|
Yaney, Alexander |
|
|
155 |
C |
p. 167-173 |
artikel |
17 |
Early alteration in apparent diffusion coefficient and tumor volume in cervical cancer treated with chemoradiotherapy or radiotherapy: Incremental prognostic value over pretreatment assessments
|
Watanabe, Yui |
|
|
155 |
C |
p. 3-9 |
artikel |
18 |
Editorial Board
|
|
|
|
155 |
C |
p. ii |
artikel |
19 |
Effect of radiotherapy interruption due to COVID-19 outbreak
|
Yu, Dongdong |
|
|
155 |
C |
p. 1-2 |
artikel |
20 |
18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO)
|
Michaelidou, A. |
|
|
155 |
C |
p. 261-268 |
artikel |
21 |
Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma
|
Grubb, William R. |
|
|
155 |
C |
p. 138-143 |
artikel |
22 |
Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer
|
Zschaeck, Sebastian |
|
|
155 |
C |
p. 204-211 |
artikel |
23 |
Genistein inhibits radiation-induced invasion and migration of glioblastoma cells by blocking the DNA-PKcs/Akt2/Rac1 signaling pathway
|
Liu, Xiongxiong |
|
|
155 |
C |
p. 93-104 |
artikel |
24 |
Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe – Results from an international survey
|
Ratosa, Ivica |
|
|
155 |
C |
p. 17-26 |
artikel |
25 |
Identification of the mutation signature of the cancer genome caused by irradiation
|
Kageyama, Shun-Ichiro |
|
|
155 |
C |
p. 10-16 |
artikel |
26 |
Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology
|
Türkkan, Görkem |
|
|
155 |
C |
p. 269-277 |
artikel |
27 |
Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study
|
Wang, H. |
|
|
155 |
C |
p. 80-85 |
artikel |
28 |
Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma
|
Liang, Shao-Bo |
|
|
155 |
C |
p. 219-225 |
artikel |
29 |
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy
|
Alongi, Filippo |
|
|
155 |
C |
p. e20-e21 |
artikel |
30 |
In reply to the letter to the editor: “In reply to Fiorino et al: The central role of the radiation oncologist in the multidisciplinary and multiprofessional model of modern radiation therapy”
|
Fiorino, Claudio |
|
|
155 |
C |
p. e22-e23 |
artikel |
31 |
In response to Bolukbasi et al
|
Sebastian, Nikhil T. |
|
|
155 |
C |
p. e11-e12 |
artikel |
32 |
In response to Chaturvedi: Professional quality of life, burnout and alexithymia
|
Tesio, Valentina |
|
|
155 |
C |
p. e6-e7 |
artikel |
33 |
In response to Goyal et al.
|
Onal, Cem |
|
|
155 |
C |
p. e15 |
artikel |
34 |
In response to Liu et al
|
Demizu, Yusuke |
|
|
155 |
C |
p. e18-e19 |
artikel |
35 |
Letter to the editor of radiotherapy and oncology regarding the article “Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan” by Demizu et al.
|
Liu, Fu-Sheng |
|
|
155 |
C |
p. e16-e17 |
artikel |
36 |
Magnetic resonance imaging guided brachytherapy: Time for non-pelvic cancer? Example of tongue brachytherapy
|
Escande, Alexandre |
|
|
155 |
C |
p. e1-e2 |
artikel |
37 |
Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network
|
Chopra, Supriya |
|
|
155 |
C |
p. 151-159 |
artikel |
38 |
MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose
|
Booth, Jeremy |
|
|
155 |
C |
p. 131-137 |
artikel |
39 |
Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial
|
Garant, Aurelie |
|
|
155 |
C |
p. 237-245 |
artikel |
40 |
Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study
|
Parry, Matthew G. |
|
|
155 |
C |
p. 48-55 |
artikel |
41 |
Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials
|
van Rossum, Peter S.N. |
|
|
155 |
C |
p. 73-79 |
artikel |
42 |
Prediction of pseudoprogression and long-term outcome of vestibular schwannoma after Gamma Knife radiosurgery based on preradiosurgical MR radiomics
|
Yang, Huai-Che |
|
|
155 |
C |
p. 123-130 |
artikel |
43 |
Professional quality of life, burnout and alexithymia
|
Chaturvedi, Santosh K. |
|
|
155 |
C |
p. e5 |
artikel |
44 |
Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer
|
Bourbonne, V. |
|
|
155 |
C |
p. 144-150 |
artikel |
45 |
Radionecrosis: Pandora’s box
|
Bolukbasi, Yasemin |
|
|
155 |
C |
p. e10 |
artikel |
46 |
Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial
|
Dietrich, Antje |
|
|
155 |
C |
p. 285-292 |
artikel |
47 |
Regional lymph node irradiation in locally advanced Merkel cell carcinoma reduces regional and distant relapse and improves disease-specific survival
|
Andruska, Neal |
|
|
155 |
C |
p. 246-253 |
artikel |
48 |
Response letter: Letter to the editor regarding Wei W et al.: ‘‘Experience of the Hubei cancer hospital in Wuhan, China”
|
Bi, Jianping |
|
|
155 |
C |
p. e8-e9 |
artikel |
49 |
Response to Escande et al.: Magnetic guided brachytherapy: Time for non-pelvic cancer? Example from tongue brachytherapy [1]
|
Kovács, György |
|
|
155 |
C |
p. e3-e4 |
artikel |
50 |
Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)
|
Ng, Sweet Ping |
|
|
155 |
C |
p. 27-32 |
artikel |
51 |
Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy
|
Smith, William H. |
|
|
155 |
C |
p. 42-47 |
artikel |
52 |
SPARC, a phase-I trial of pre‐operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer
|
Holyoake, Daniel L.P. |
|
|
155 |
C |
p. 278-284 |
artikel |
53 |
The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer
|
Amin, Saber A. |
|
|
155 |
C |
p. 254-260 |
artikel |
54 |
Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group
|
Hoeben, Bianca A.W. |
|
|
155 |
C |
p. 113-119 |
artikel |
55 |
Ureteral stenosis after 3D MRI-based brachytherapy for cervical cancer – Have we identified all the risk factors?
|
Rodríguez-López, Joshua L. |
|
|
155 |
C |
p. 86-92 |
artikel |